글로벌 쇼그렌 증후군 시장 - 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 글로벌 쇼그렌 증후군 시장

쇼그렌 증후군 시장은 2022-2029년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 4.50%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다. 쇼그렌 증후군의 발병률 증가와 이 질병에 대한 강력한 파이프라인의 존재는 이 시장 성장에 도움이 됩니다.

쇼그렌 증후군은 입과 눈의 수분 부족을 유발하는 자가면역 질환과 관련이 있습니다. 이 증후군은 자가면역 질환 및 루푸스와 같은 대체 시스템 장애와 관련이 있습니다. 이 증후군의 가장 중요한 증상은 눈과 입의 수분 부족이며, 그 다음으로 관절 통증, 분비선 부종 등이 있습니다. 쇼그렌 증후군에는 1차 쇼그렌 증후군과 2차 쇼그렌 증후군의 두 가지 종류가 있습니다.

쇼그렌 증후군 및 기타 자가면역 질환의 발병률 증가가 시장 성장을 주도하고 있습니다. 또한, 예방적 주의에 대한 인식이 높아지고 인구의 소득이 증가함에 따라 쇼그렌 의학 및 의료 전문 시장이 확대될 것으로 예상됩니다. 또한, 엄격한 정부 법률, 약물의 부작용, 높은 주의 가치 및 경화증 영역의 진단 검사는 시장 확장에 대한 주요 장벽입니다. 지속적으로 경화증 진단 및 의료 전문 분야 내에서 R&D가 예상 기간 내내 새로운 기회를 창출할 것으로 예상됩니다.

그러나 쇼그렌 증후군과 관련된 높은 치료 비용과 심각한 탈수, 상당한 체중 감소 및 염증과 같은 합병증은 시장 성장을 방해하는 요인입니다. 질병과 예방 조치에 대한 인식 부족과 약물의 부작용은 위에서 언급한 예측 기간 동안 쇼그렌 증후군 시장에 도전이 될 것입니다.

This Sjögren’s syndrome market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Sjögren’s syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Sjögren’s Syndrome Market Scope and Market Size

The sjögren’s syndrome market is segmented on the basis of type, symptoms, diagnosis, treatment, drugs, end users, and distribution channels. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the Sjögren’s syndrome market is segmented into primary Sjögren’s syndrome, and secondary Sjögren’s syndrome.
• On the basis of symptoms, the Sjögren’s syndrome market is segmented into dry eyes, dry mouth, and others.
• On the basis of diagnosis, the Sjögren’s syndrome market is segmented into blood tests, eye tests, lip biopsy, and others.
• On the basis of treatment, the Sjögren’s syndrome market is segmented into medication, surgery, and others.
• On the basis of drugs, the Sjögren’s syndrome market is segmented into salagen, evoxac, plaquenil, and others.
• On the basis of end users, the Sjögren’s syndrome market is segmented into hospitals, homecare, specialty, clinics, and others.
• On the basis of distribution channels, the Sjögren’s syndrome market is segmented into hospital pharmacy, online pharmacy, retail pharmacy, and others.

Sjögren’s Syndrome Market Country Level Analysis

Sjögren’s Syndrome Market is analysed and market size information is provided by the country, type, symptoms, diagnosis, treatment, drugs, end users, and distribution channels as referenced above.

The countries covered in the Sjögren’s syndrome market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the Sjögren’s syndrome market due to the presence of major key players, high disposable income and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The region covered in the Sjögren’s syndrome market report are the North America, South America, Europe, Asia-Pacific, Middle East and Africa. The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Sjögren’s syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Sjögren’s Syndrome Market Share Analysis

Sjögren’s syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Sjögren’s syndrome market.

The major players operating in the Sjögren’s syndrome market report are, Advanz Pharmaceutical, Eisai Co., Ltd.,., Novartis AG, AstraZeneca, Genentech, Inc., Nicox, ALLERGAN, Biogen, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Amgen Inc., Lupin, Kissei Pharmaceutical Co., Ltd., Pfizer Inc., Santen Pharmaceutical Co., Ltd., Bausch Health, Resolve Therapeutics, Wize Pharma Inc., among others.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-50394